Low Total Lymphocyte Count Is Associated with Poor Survival in Patients with Resected Pancreatic Adenocarcinoma Receiving a GM-CSF Secreting Pancreatic Tumor Vaccine

被引：0
|
作者：
Aaron J. Schueneman
Elizabeth A. Sugar
Jennifer Uram
Elaine Bigelow
Joseph M. Herman
Barish H. Edil
Elizabeth M. Jaffee
Lei Zheng
Daniel A. Laheru
机构：
[1] Johns Hopkins University School of Medicine,Department of Oncology
[2] Johns Hopkins University School of Medicine,Department of Medicine
[3] Johns Hopkins University School of Medicine,Department of Surgery
[4] Johns Hopkins University School of Medicine,Department of Radiation Oncology
[5] Johns Hopkins University School of Medicine,The Skip Viragh Center for Pancreatic Cancer Research and Clinical Care
[6] Johns Hopkins University School of Medicine,The Sol Goldman Pancreatic Cancer Center
[7] Johns Hopkins University,Departments of Biostatistics and Epidemiology, Bloomberg School of Public Health
[8] University of Colorado,Pancreas and Biliary Surgery Program, Department of Surgery
来源：
Annals of Surgical Oncology | 2013年 / 20卷
关键词：
Overall Survival; Pancreatic Cancer; Complete Blood Count; Lymphocyte Count; Ipilimumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：725 / 730
页数：5
相关论文
共 50 条
  • [1] Low Total Lymphocyte Count Is Associated with Poor Survival in Patients with Resected Pancreatic Adenocarcinoma Receiving a GM-CSF Secreting Pancreatic Tumor Vaccine
    Schueneman, Aaron J.
    Sugar, Elizabeth A.
    Uram, Jennifer
    Bigelow, Elaine
    Herman, Joseph M.
    Edil, Barish H.
    Jaffee, Elizabeth M.
    Zheng, Lei
    Laheru, Daniel A.
    ANNALS OF SURGICAL ONCOLOGY, 2013, 20 : S725 - S730
  • [2] Association of low total lymphocyte count with overall and disease-free survival in patients with resected pancreatic adenocarcinoma receiving the GM-CSF secreting pancreatic tumor vaccine in combination with adjuvant chemoradiation
    Schueneman, Aaron
    Sugar, Elizabeth
    Uram, Jennifer
    Bigelow, Elaine
    Herman, Joseph M.
    Edil, Barish H.
    Jaffee, Elizabeth M.
    Zheng, Lei
    Laheru, Dan
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [3] Antibody response in pancreatic cancer patients vaccinated with an allogeneic GM-CSF secreting tumor vaccine
    Huang, Lanqing
    Dudik, Allison
    Mo, Guanglan
    Zheng, Lei
    Laheru, Dan
    Jaffee, Elizabeth
    CANCER RESEARCH, 2009, 69
  • [4] Preliminary Results of a Pilot Study Evaluating An Allogeneic GM-CSF Pancreatic Tumor Cell Vaccine (GVAX) and Cytoxan (Cy) With Stereotactic Body Radiation Therapy (SBRT) and Folfirinox (FFX) in Patients With Resected Pancreatic Adenocarcinoma
    Herman, J. M.
    Parkinson, R.
    Onners, B.
    Rao, A. D.
    Zheng, L.
    Le, D. T.
    De Jesus-Acosta, A.
    Lutz, E.
    Hruban, R. H.
    Hirose, K.
    Fishman, E. K.
    Weiss, M. J.
    Hacker-Prietz, A.
    Pawlik, T. M.
    Cameron, J. L.
    Wolfgang, C. L.
    Jaffee, E. M.
    Laheru, D. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : S154 - S154
  • [5] Excellent Survival of Low-Risk Patients With Resected Pancreatic Adenocarcinoma
    Hartwig, W.
    Hackert, T.
    Gluth, A.
    Hinz, U.
    Bergmann, F.
    Buechler, M. W.
    Werner, J.
    PANCREAS, 2010, 39 (08) : 1322 - 1322
  • [6] A phase I clinical trial of lethally irradiated allogeneic pancreatic tumor cells transfected with the GM-CSF gene for the treatment of pancreatic adenocarcinoma
    Jaffee, EM
    Abrams, R
    Cameron, J
    Donehower, R
    Duerr, M
    Gossett, J
    Greten, TF
    Grochow, L
    Hruban, R
    Kern, S
    Lillemoe, KD
    O'Reilly, S
    Pardoll, D
    Pitt, HA
    Sauter, P
    Weber, C
    Yeo, C
    HUMAN GENE THERAPY, 1998, 9 (13) : 1951 - 1969
  • [7] EGFR, but not COX-2, protein in resected pancreatic ductal adenocarcinoma is associated with poor survival
    Fagman, Johan Bourghardt
    Ljungman, David
    Falk, Peter
    Iresjo, Britt-Marie
    Engstrom, Cecilia
    Naredi, Peter
    Lundholm, Kent
    ONCOLOGY LETTERS, 2019, 17 (06) : 5361 - 5368
  • [8] Conditional Survival in Resected Pancreatic Ductal Adenocarcinoma Patients Treated with Total Neoadjuvant Therapy
    Theodoros Michelakos
    Yurie Sekigami
    Filippos Kontos
    Carlos Fernández-del Castillo
    Motaz Qadan
    Vikram Deshpande
    David T. Ting
    Jeffrey W. Clark
    Colin D. Weekes
    Aparna Parikh
    David P. Ryan
    Jennifer Y. Wo
    Theodore S. Hong
    Jill N. Allen
    Onofrio Catalano
    Andrew L. Warshaw
    Keith D. Lillemoe
    Cristina R. Ferrone
    Journal of Gastrointestinal Surgery, 2021, 25 : 2859 - 2870
  • [9] Conditional Survival in Resected Pancreatic Ductal Adenocarcinoma Patients Treated with Total Neoadjuvant Therapy
    Michelakos, Theodoros
    Sekigami, Yurie
    Kontos, Filippos
    Fernandez-del Castillo, Carlos
    Qadan, Motaz
    Deshpande, Vikram
    Ting, David T.
    Clark, Jeffrey W.
    Weekes, Colin D.
    Parikh, Aparna
    Ryan, David P.
    Wo, Jennifer Y.
    Hong, Theodore S.
    Allen, Jill N.
    Catalano, Onofrio
    Warshaw, Andrew L.
    Lillemoe, Keith D.
    Ferrone, Cristina R.
    JOURNAL OF GASTROINTESTINAL SURGERY, 2021, 25 (11) : 2859 - 2870
  • [10] Tumor Differentiation Impacts Survival in Pancreatic Adenocarcinoma Patients Receiving Preoperative Therapy
    Lindberg, J. M.
    Prakash, L. R.
    Gonzalez, G. M. Nogueras
    Conrad, C.
    Vauthey, J.
    Aloia, T.
    Tzeng, C.
    Fleming, J. B.
    Lee, J. E.
    Katz, M.
    Kim, M.
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 : S32 - S32
12345